P

Inventor

FLEURY MELISSA

US98 patents
⚠️ This page may combine multiple inventors who share the name “FLEURY MELISSA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THERAVANCE BIOPHARMA R&D IP LLC

24 patents
US10526330B2Jan 7, 2020

JAK kinase inhibitor compounds for treatment of respiratory disease

THERAVANCE BIOPHARMA R&D IP LLC15 citations94
US10189823B2Jan 29, 2019

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC9 citations93
US10100049B2Oct 16, 2018

JAK kinase inhibitor compounds for treatment of respiratory disease

THERAVANCE BIOPHARMA R&D IP LLC28 citations93
US10028960B2Jul 24, 2018

Pyrimidine compounds as JAK kinase inhibitors

THERAVANCE BIOPHARMA R&D IP LLC18 citations93
US9873685B2Jan 23, 2018

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC10 citations93
US9725470B2Aug 8, 2017

Substituted naphthyridines as JAK kinase inhibitors

THERAVANCE BIOPHARMA R&D IP LLC27 citations93
US10570120B2Feb 25, 2020

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC6 citations84
US10172834B2Jan 8, 2019

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US10123984B2Nov 13, 2018

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US9884807B2Feb 6, 2018

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US9872855B2Jan 23, 2018

(2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

THERAVANCE BIOPHARMA R&D IP LLC5 citations84
US9845332B2Dec 19, 2017

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC7 citations84
US9688692B2Jun 27, 2017

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC7 citations84
US9533962B2Jan 3, 2017

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

THERAVANCE BIOPHARMA R&D IP LLC6 citations84
US10752599B2Aug 25, 2020

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

THERAVANCE BIOPHARMA R&D IP LLC3 citations82
US10472335B2Nov 12, 2019

Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

THERAVANCE BIOPHARMA R&D IP LLC4 citations82
US10100021B2Oct 16, 2018

Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

THERAVANCE BIOPHARMA R&D IP LLC4 citations82
US11299492B2Apr 12, 2022

JAK kinase inhibitor compounds for treatment of respiratory disease

THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US11261197B2Mar 1, 2022

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC1 citations73
US11230536B2Jan 25, 2022

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US11124502B2Sep 21, 2021

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US11033533B2Jun 15, 2021

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

THERAVANCE BIOPHARMA R&D IP LLC1 citations73
US10829438B2Nov 10, 2020

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC1 citations73
US10744104B2Aug 18, 2020

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC2 citations73

FLEURY MELISSA

6 patents

HUGHES ADAM D

5 patents

THERAVANCE RESPIRATORY CO LLC

4 patents

GENDRON ROLAND

3 patents

THERAVANCE INC

2 patents

FENSTER ERIK

2 patents

SMITH CAMERON

1 patent

HUGHES ADAM

1 patent

GILEAD SCIENCES INC

1 patent

BLAIR BROOKE

1 patent

Showing the top 50 of 98 patents by PatentIndex Score.